Anterior Thigh Muscle Fat Infiltration
Introduction
Section titled “Introduction”Background
Section titled “Background”Anterior thigh muscle fat infiltration refers to the accumulation of adipose tissue within and between the muscle fibers of the quadriceps femoris and other muscles located at the front of the thigh. This phenomenon, also known as intramuscular or intermuscular fat, is distinct from subcutaneous fat (fat under the skin) and visceral fat (fat around organs). It can be quantified using various imaging techniques, such as magnetic resonance imaging (MRI) or computed tomography (CT) scans, which allow for a detailed assessment of tissue composition.
Biological Basis
Section titled “Biological Basis”The biological mechanisms underlying anterior thigh muscle fat infiltration are complex and multifactorial. It is often associated with aging, where there is a natural decline in muscle mass (sarcopenia) and a concomitant increase in fat accumulation within muscle tissue. Metabolic dysfunction, such as insulin resistance and type 2 diabetes, also plays a significant role, as altered lipid metabolism can promote ectopic fat deposition. Chronic inflammation, sedentary lifestyles, and certain genetic predispositions can further contribute to the development and progression of muscle fat infiltration.
Clinical Relevance
Section titled “Clinical Relevance”From a clinical perspective, anterior thigh muscle fat infiltration is a significant indicator of musculoskeletal health and overall metabolic status. High levels of muscle fat infiltration are linked to reduced muscle quality, decreased muscle strength, and impaired physical function, increasing the risk of falls and disability, particularly in older adults. It is also recognized as a biomarker for various metabolic disorders, including cardiovascular disease and type 2 diabetes, reflecting a broader systemic metabolic imbalance. Its presence can exacerbate conditions like osteoarthritis and complicate recovery from injuries or surgeries.
Social Importance
Section titled “Social Importance”The widespread prevalence of anterior thigh muscle fat infiltration, especially in aging populations and individuals with metabolic syndrome, makes it a matter of substantial social importance. Its impact on mobility and independence can significantly diminish quality of life and increase healthcare burdens due to long-term care needs and associated comorbidities. Understanding and addressing muscle fat infiltration through lifestyle interventions, targeted therapies, and public health initiatives can help promote healthy aging, improve functional independence, and reduce the societal costs associated with age-related decline and chronic metabolic diseases.
Limitations
Section titled “Limitations”Methodological Constraints and Statistical Power
Section titled “Methodological Constraints and Statistical Power”The interpretation of findings regarding anterior thigh muscle fat infiltration is subject to several methodological and statistical constraints. Many studies utilized genotyping platforms with partial coverage, such as the Affymetrix 100K gene chip, which may not capture all relevant genetic variation within a region or comprehensively assay candidate genes ThePEPD gene, linked to rs4805881 , encodes a peptidase involved in peptide hydrolysis, a process essential for protein turnover and potentially for signaling pathways that indirectly affect metabolic health and inflammation, which can contribute to fat infiltration. ThePDE3A gene, near rs7298820 , encodes phosphodiesterase 3A, an enzyme that regulates intracellular cyclic AMP and cyclic GMP levels, thereby influencing critical cellular processes such as lipolysis (fat breakdown) and insulin signaling. Alterations inPDE3A activity due to variants like rs7298820 could impact overall energy balance and the propensity for fat accumulation in various tissues, including the anterior thigh muscles. [1]
Long non-coding RNAs (lncRNAs) and their associated genes also contribute to metabolic regulation. LINC02227, a lncRNA, is located near EBF1, a transcription factor essential for B-cell development and adipogenesis, with rs17055818 representing a variant in this region. Changes in the expression or function of EBF1or its regulatory lncRNA could alter fat cell differentiation and thus affect muscle fat infiltration. Similarly, LINC02630 is an lncRNA associated with the pseudogeneMTND5P17 (rs10827614 ), which is related to mitochondrial NADH dehydrogenase 5, highlighting a potential link to mitochondrial function and cellular energy metabolism. The THORLNC-LINC01956 region, represented by rs6723391 , involves two lncRNAs that can regulate gene expression through various mechanisms, and their dysregulation may contribute to metabolic disorders impacting fat accumulation. Genome-wide association studies have consistently identified numerous genetic regions influencing metabolic traits, supporting the broad impact of genetic variation on these complex processes. [2]
Further variants influence metabolic pathways and structural integrity relevant to muscle fat. TheST13P19 pseudogene and HHAT gene, with rs635084 , are of interest because HHAT(Ghrelin O-acyltransferase) is crucial for the acylation of ghrelin, a hormone that stimulates appetite and influences energy balance. Variants affectingHHATcould alter ghrelin activity, leading to changes in body weight and fat distribution. TheFGF9 gene, associated with rs646026 and near the RN7SL766P pseudogene, encodes Fibroblast Growth Factor 9, a protein involved in cell growth, development, and metabolism, including aspects of energy homeostasis and adiposity. The LYPLAL1-AS1 lncRNA, with variant rs2820465 , is an antisense transcript to LYPLAL1, a gene linked to fat distribution and obesity. Variations in this region have been implicated in various metabolic traits and lipid concentrations.[1] Lastly, the DYSF gene, associated with rs11678046 and near the RPS20P10 pseudogene, encodes dysferlin, a protein critical for muscle repair. While primarily involved in muscle integrity, healthy muscle structure and efficient repair mechanisms are important for preventing conditions that can lead to increased fat infiltration, such as those seen in muscular dystrophies or age-related sarcopenia. Genetic variations impacting muscle health can indirectly influence the extent of fat accumulation within muscle tissue.[3]
Causes of Anterior Thigh Muscle Fat Infiltration
Section titled “Causes of Anterior Thigh Muscle Fat Infiltration”Anterior thigh muscle fat infiltration, a condition characterized by the accumulation of adipose tissue within muscle fibers, is a complex trait influenced by a combination of genetic predispositions, environmental factors, developmental influences, and various comorbidities. Research, often utilizing genome-wide association studies (GWAS) and population cohorts, has begun to unravel the intricate mechanisms underlying this phenomenon, frequently linking it to broader metabolic dysregulation.
Genetic Predisposition and Lipid Metabolism
Section titled “Genetic Predisposition and Lipid Metabolism”Genetic factors play a significant role in determining an individual’s susceptibility to fat infiltration, particularly through their influence on lipid metabolism. Studies have identified numerous single nucleotide polymorphisms (SNPs) and gene regions associated with circulating lipid levels, which are often implicated in fat deposition. For instance, associations have been replicated for SNPs within genes such asGCKR and LPL, as well as regions like ANGPTL3-DOCK7-ATG4C and BCL7B-TBL2-MLXIPL, all of which are linked to triglyceride levels.[4] A newly identified association on chromosome 15, dependent on rs2624265 , also contributes to triglyceride variability.[4] Furthermore, the APOA1/APOC3/APOA5 gene cluster is strongly associated with lipid traits, with variants like rs6589566 impacting serum triglyceride levels[2]. [1] A null mutation in human APOC3 has even been shown to confer a favorable plasma lipid profile and apparent cardioprotection. [5] The androgen receptor gene, AR, on chromosome X, particularly rs5031002 , exhibits a substantial effect size on lipid traits, suggesting a sex-specific genetic influence.[4] These genetic variants often contribute to a polygenic risk for dyslipidemia [6] which can directly contribute to ectopic fat deposition in muscles.
Environmental and Lifestyle Modulators
Section titled “Environmental and Lifestyle Modulators”Beyond genetics, various environmental and lifestyle factors significantly modulate the risk and severity of anterior thigh muscle fat infiltration. Dietary habits, particularly those affecting lipid profiles, are crucial. For example, individuals are often excluded from lipid trait analysis if they have not fasted before blood collection, highlighting the immediate impact of diet on metabolic markers.[4]Body Mass Index (BMI) is a well-established environmental variable that strongly correlates with metabolic traits, and its adjustment in genetic association analyses, such as for theFADS1-FADS2 locus on chromosome 11, indicates its independent and interactive role in fat metabolism. [4]The presence of environmental variables, alongside genetic associations, explains a portion of the total trait variability, suggesting that lifestyle choices and exposures contribute substantially to the development of fat infiltration.[4]The overall body composition and weight-related health conditions are also considered important factors in studies investigating functional limitations.[7]
Developmental Origins and Early Life Factors
Section titled “Developmental Origins and Early Life Factors”Early life experiences and developmental factors can program an individual’s susceptibility to fat infiltration later in life. Studies utilizing birth cohorts, such as the Northern Finland 1966 Birth Cohort (NFBC1966), provide insights into these long-term effects[7]. [4]Researchers have specifically considered the effects of gestational age and birth weight, recognizing their established relationship with the risk for cardiovascular disease (CVD) and type 2 diabetes (T2D).[4]These early life influences can set trajectories for metabolic health, potentially affecting muscle development and fat deposition patterns as individuals age. While epigenetic factors like DNA methylation are not explicitly detailed in the provided context, the focus on birth cohorts and early life conditions underscores the importance of developmental programming in the etiology of complex metabolic traits.
Age, Comorbidities, and Pharmacological Influences
Section titled “Age, Comorbidities, and Pharmacological Influences”The risk of anterior thigh muscle fat infiltration is also influenced by aging, the presence of various comorbidities, and the use of certain medications. Age and sex are frequently included as covariates in genetic models, acknowledging their pervasive impact on metabolic traits.[7]As individuals age, changes in body composition and metabolic regulation can predispose them to increased fat infiltration. Comorbidities, such as diabetes, are recognized as significant contributors to metabolic dysregulation and are often criteria for exclusion in studies focusing on primary lipid traits, indicating their profound impact on the studied phenotypes.[4] Furthermore, pharmacological interventions can influence metabolic health; for example, blood pressure measurements are adjusted for individuals on blood pressure medication to account for their therapeutic effects. [4]These factors collectively illustrate how an individual’s health status and medical management contribute to the overall risk profile for muscle fat infiltration.
Biological Background of Anterior Thigh Muscle Fat Infiltration
Section titled “Biological Background of Anterior Thigh Muscle Fat Infiltration”Cellular and Molecular Drivers of Adipogenesis and Inflammation
Section titled “Cellular and Molecular Drivers of Adipogenesis and Inflammation”Adipogenesis, the complex process of fat cell formation, is a fundamental mechanism underlying anterior thigh muscle fat infiltration, and it is significantly influenced by the body’s metabolic state. For example, theADIPONUTRINgene is regulated by insulin and glucose within human adipose tissue, and variations in this gene can impact its expression and are associated with obesity.[8]This highlights a direct interplay between nutrient availability, genetic predisposition, and the accumulation of fat cells within muscle tissue.
Inflammation also plays a critical role in promoting fat infiltration, involving key biomolecules such as TNF-alpha (Tumor Necrosis Factor-alpha), IL-6sR (Interleukin-6 soluble receptor), and CRP(C-reactive protein).TNF-alphais a potent pro-inflammatory cytokine, and its baseline levels have been investigated in relation to changes in body composition, suggesting its involvement in adipose tissue dynamics.[7]These inflammatory mediators can foster an environment within muscle that encourages adipocyte differentiation and disrupts the normal functions of muscle cells. The MAPK (mitogen-activated protein kinase) pathway, known to be activated in human skeletal muscle, is also implicated in cellular stress responses and inflammation, potentially contributing to tissue remodeling and fat deposition.[9]
Genetic Determinants of Lipid Metabolism and Body Composition
Section titled “Genetic Determinants of Lipid Metabolism and Body Composition”Genetic mechanisms significantly contribute to an individual’s susceptibility to anterior thigh muscle fat infiltration, primarily by influencing lipid metabolism and overall body composition. Common genetic variations near theMC4R(Melanocortin 4 Receptor) gene are associated with various metabolic traits, including waist circumference, insulin resistance, fat mass, and a heightened risk of obesity.[8]These traits are well-established risk factors that can predispose individuals to increased fat accumulation within muscle tissue.
Several other genes also play crucial roles in regulating plasma lipid levels, thereby indirectly affecting muscle fat infiltration. Genes such asMLXIPL (MLX Interacting Protein Like), GCKR(Glucokinase Regulator),LPL(Lipoprotein Lipase), and theAPOA1/C3/A4/A5gene cluster are known to influence plasma triglyceride levels and high-density lipoprotein (HDL) cholesterol.[10] Notably, a null mutation in human APOC3(Apolipoprotein C-III) has been observed to result in a favorable plasma lipid profile and apparent cardioprotection[5] underscoring how specific genetic variants can protect against dyslipidemia, a condition often associated with increased fat infiltration.
Systemic Metabolic and Hormonal Regulation
Section titled “Systemic Metabolic and Hormonal Regulation”The systemic metabolic environment, characterized by the circulating levels of critical biomolecules like insulin, glucose, and various lipids, profoundly impacts muscle health and the likelihood of fat infiltration. Elevated concentrations of triglycerides (TG) and unfavorable cholesterol profiles, including total cholesterol and HDL, are hallmarks of dyslipidemia.[10] This metabolic imbalance creates a conducive environment for the ectopic deposition of fat in non-adipose tissues, such as the anterior thigh muscles.
Hormonal regulation also plays a pivotal role in modulating fat distribution and metabolic health. Proteins like SHBG(Sex Hormone Binding Globulin) are important for transporting sex hormones, which in turn can influence body composition and the propensity for fat accumulation.[7]Furthermore, disruptions in glucose metabolism, particularly insulin resistance, lead to chronic hyperglycemia and increased availability of free fatty acids, which can significantly exacerbate the infiltration of fat within muscle tissue.[10]
Pathophysiological Remodeling of Muscle Tissue
Section titled “Pathophysiological Remodeling of Muscle Tissue”Anterior thigh muscle fat infiltration represents a significant pathophysiological process where functional muscle tissue is gradually replaced or infiltrated by adipose tissue, leading to a disruption of normal homeostatic function. This detrimental tissue remodeling is frequently a consequence of chronic low-grade inflammation, evidenced by elevated circulating levels of inflammatory markers such asCRP and TNF-alpha. [7]These inflammatory signals can contribute to a hostile microenvironment within the muscle, impairing its regenerative capacity.
The intricate interplay between metabolic dysfunction and persistent inflammation can trigger undesirable cellular changes within the muscle’s local environment. This often promotes the differentiation of resident mesenchymal stem cells into adipocytes (fat cells) instead of myoblasts (muscle cells), thereby facilitating fat accumulation and diminishing muscle quality. Lipid metabolism pathways, including those involving polyunsaturated fatty acids (PUFAs) and phosphatidylcholines, which are modulated by enzymes such asFADS1 (Fatty Acid Desaturase 1) [11]further contribute to this process, leading to the progressive degradation of muscle architecture and function.
Pathways and Mechanisms
Section titled “Pathways and Mechanisms”Regulation of Lipid Uptake, Synthesis, and Storage
Section titled “Regulation of Lipid Uptake, Synthesis, and Storage”Anterior thigh muscle fat infiltration is significantly influenced by pathways governing lipid metabolism. Key regulatory proteins, such as apolipoprotein C-III (APOC3), play a crucial role by inhibiting lipoprotein lipase (LPL), an enzyme essential for breaking down triglycerides in circulating lipoproteins, thereby affecting their uptake by tissues. A null mutation in APOC3has been observed to lead to a favorable plasma lipid profile, characterized by reduced fasting and post-prandial triglycerides, and increased high-density lipoprotein (HDL) levels, suggesting its critical role in systemic lipid clearance.[5] Similarly, angiopoietin-like protein 4 (ANGPTL4) acts as a potent inhibitor of LPLand a factor inducing hyperlipidemia, with variations in its gene leading to reduced triglycerides and elevated HDL, indicating a direct impact on lipid catabolism and the propensity for fat accumulation within non-adipose tissues like muscle.[12]
The synthesis of lipids also contributes to muscle fat infiltration, with enzymes like 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) being central to cholesterol biosynthesis, a pathway that can be dysregulated in metabolic disorders. [13]The glucokinase regulatory protein (GCKR) and MLXIPL(which encodes a transcription factor involved in lipogenesis) are also implicated, with genetic variations in these genes associated with plasma triglyceride levels, highlighting their role in controlling hepatic lipid output and overall systemic lipid burden.[4] Furthermore, the patatin-like phospholipase family, including Adiponutrin, is involved in triglyceride metabolism, with its expression in human adipose tissue being regulated by insulin and glucose, and genetic variations influencing obesity and potentially local fat deposition.[14]
Glucose Homeostasis and Energy Sensing Pathways
Section titled “Glucose Homeostasis and Energy Sensing Pathways”The interplay between glucose metabolism and insulin signaling is a fundamental determinant of fat deposition, including in anterior thigh muscles. The melanocortin 4 receptor (MC4R) signaling pathway is crucial for energy balance, with common genetic variations near MC4Rlinked to increased waist circumference, insulin resistance, higher fat mass, and an elevated risk of obesity.[15]Dysregulation in this pathway can alter appetite and energy expenditure, thereby indirectly promoting systemic fat accumulation that may extend to muscle tissue. TheFTO gene also plays a significant role in metabolic regulation, as variants in FTOinfluence adiposity, insulin sensitivity, leptin levels, and resting metabolic rate, directly impacting the body’s fat storage capacity and energy utilization.[16]
Moreover, the initial steps of glucose utilization are critical, with hexokinase 1 (HK1) catalyzing the phosphorylation of glucose, thereby committing it to glycolytic pathways.[17] Alterations in HK1function or expression can impact cellular glucose flux, potentially shunting excess glucose towards de novo lipogenesis if other metabolic demands are met, contributing to fat accumulation. The regulation of genes likeAdiponutrinby insulin and glucose further illustrates the intricate feedback loops where nutrient availability directly influences the expression of genes involved in lipid metabolism, creating a dynamic environment that can either prevent or promote fat infiltration.[18]
Inflammatory Signaling and Cellular Crosstalk
Section titled “Inflammatory Signaling and Cellular Crosstalk”Chronic low-grade inflammation and altered cellular communication contribute significantly to the pathological processes underlying muscle fat infiltration. Pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha), interleukin-18 (IL18), and components of the interleukin-6 signaling pathway (IL-6sR), are known to dysregulate cellular metabolism and promote adipogenesis in non-adipose tissues. [7]Elevated levels of these inflammatory mediators can impair insulin signaling in muscle cells and stimulate the differentiation of pre-adipocytes, leading to increased fat deposition within the muscle. The activation of the mitogen-activated protein kinase (MAPK) pathway, controlled by protein families like human tribbles, also plays a role in cellular responses to stress and metabolic changes in skeletal muscle, potentially modulating the inflammatory environment.[19]
Furthermore, signaling molecules like angiotensin II can impact vascular smooth muscle cells by increasing phosphodiesterase 5A expression, which antagonizes cGMP signaling and affects vascular tone.[20]While primarily affecting vascular function, such systemic signaling alterations can indirectly influence nutrient delivery and waste removal in muscle tissue, contributing to a microenvironment conducive to fat infiltration. The complex crosstalk between inflammatory pathways, metabolic regulators, and vascular signaling ultimately determines the susceptibility of anterior thigh muscles to ectopic lipid accumulation, often representing a systemic metabolic dysregulation with local consequences.
Transcriptional and Post-Translational Control of Metabolism
Section titled “Transcriptional and Post-Translational Control of Metabolism”The precise regulation of gene expression and protein activity is paramount in preventing or promoting fat infiltration in anterior thigh muscles. Transcription factors, such as MLXIPL and SREBP-2 (Sterol Regulatory Element-Binding Protein 2), serve as master regulators of lipid metabolism, controlling the expression of genes involved in fatty acid synthesis and cholesterol biosynthesis, respectively. [21] Their activity is tightly controlled by nutrient availability and hormonal signals, ensuring that lipid synthesis is coordinated with the body’s energy status. Dysregulation in the activation or repression of these transcription factors can lead to excessive lipid production, contributing to ectopic fat deposition.
Beyond transcriptional control, post-translational modifications and alternative splicing significantly modulate protein function and abundance. For instance, common single nucleotide polymorphisms inHMGCR affect the alternative splicing of exon 13, influencing the structure and potentially the activity of this crucial cholesterol synthesis enzyme. [13] Proteins like human tribbles, which control mitogen-activated protein kinase cascades, also exemplify post-translational regulatory mechanisms that integrate various cellular signals to modulate metabolic pathways. [19]These intricate regulatory layers, including allosteric control and feedback loops, ensure dynamic adaptation of metabolic flux, but their dysregulation can lead to persistent metabolic imbalances favoring fat infiltration within muscle tissue.
Key Variants
Section titled “Key Variants”| RS ID | Gene | Related Traits |
|---|---|---|
| rs4805881 | PEPD | high density lipoprotein cholesterol measurement sex hormone-binding globulin measurement leukocyte quantity myeloid leukocyte count lymphocyte count |
| rs2881654 | PPARG | body mass index, type 2 diabetes mellitus body fat percentage, type 2 diabetes mellitus body fat percentage, blood insulin amount body mass index, blood insulin amount waist-hip ratio, type 2 diabetes mellitus |
| rs7298820 | PDE3A | spinal stenosis sex hormone-binding globulin measurement anterior thigh muscle fat infiltration measurement posterior thigh muscle fat infiltration measurement |
| rs17055818 | LINC02227 - EBF1 | lymphocyte count neutrophil percentage of leukocytes anterior thigh muscle fat infiltration measurement body composition measurement |
| rs10827614 | LINC02630 - MTND5P17 | posterior thigh muscle fat infiltration measurement anterior thigh muscle fat infiltration measurement |
| rs6723391 | THORLNC - LINC01956 | anterior thigh muscle fat infiltration measurement |
| rs635084 | ST13P19 - HHAT | anterior thigh muscle fat infiltration measurement posterior thigh muscle fat infiltration measurement |
| rs646026 | FGF9 - RN7SL766P | anterior thigh muscle fat infiltration measurement body composition measurement |
| rs2820465 | LYPLAL1-AS1 | Umbilical hernia anterior thigh muscle fat infiltration measurement posterior thigh muscle fat infiltration measurement |
| rs11678046 | DYSF - RPS20P10 | anterior thigh muscle fat infiltration measurement |
References
Section titled “References”[1] Willer, C. J., et al. “Newly identified loci that influence lipid concentrations and risk of coronary artery disease.”Nat Genet, vol. 40, no. 2, 2008, pp. 161-169.
[2] Wallace, C., et al. “Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.”Am J Hum Genet, vol. 82, no. 1, 2008, pp. 139-149.
[3] O’Donnell, C. J., et al. “Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI’s Framingham Heart Study.”BMC Medical Genetics, vol. 8, 2007, p. S13.
[4] Sabatti, C., et al. “Genome-wide association analysis of metabolic traits in a birth cohort from a founder population.”Nat Genet, 2008, 40: 1391–1402.
[5] Pollin, T. I., et al. “A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection.” Science, vol. 322, no. 5906, 2008, pp. 1702-1705.
[6] Kathiresan, S., et al. “Common variants at 30 loci contribute to polygenic dyslipidemia.” Nat Genet, 2008, 40: 149–151.
[7] Melzer, D., et al. “A genome-wide association study identifies protein quantitative trait loci (pQTLs).” PLoS Genet, 2008, 4: e1000072.
[8] Yuan, Xin, et al. “Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.” Am J Hum Genet, vol. 83, no. 5, 2008, pp. 547-56.
[9] Vasan, R. S., et al. “Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study.”BMC Med Genet, vol. 8, 2007, p. 57.
[10] Sabatti, C., et al. “Genome-wide association analysis of metabolic traits in a birth cohort from a founder population.”Nature Genetics, vol. 41, no. 1, 2009, pp. 35-46.
[11] Gieger, Christian, et al. “Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum.”PLoS Genet, vol. 4, no. 11, 2008, p. e1000282.
[12] Yoshida, K., et al. “Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase.”J Lipid Res, 2002, 43: 1770–1772.
[13] Burkhardt, R., et al. “Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13.” Arterioscler Thromb Vasc Biol, 2009, 29: 395-401.
[14] Wilson, P.A., et al. “Characterization of the human patatin-like phospholipase family.” J Lipid Res, 2006, 47: 1940–1949.
[15] Loos, R.J., et al. “Common variants near MC4R are associated with fat mass, weight and risk of obesity.”Nat Genet, 2008, 40: 768–775.
[16] Do, R., et al. “Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI.” Diabetes, 2008, 57: 1419–1426.
[17] Pare, G., et al. “Novel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women’s Genome Health Study.”PLoS Genet, 2008, 4: e1000312.
[18] Moldes, M., et al. “Adiponutrin gene is regulated by insulin and glucose in human adipose tissue.”Eur J Endocrinol, 2006, 155: 149-156.
[19] Kiss-Toth, E., et al. “Human tribbles, a protein family controlling mitogen-activated protein kinase cascades.” J Biol Chem, 2004, 279: 42703–42708.
[20] Kim, D., et al. “Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling.”J Mol Cell Cardiol, 2005, 38: 175–184.
[21] Kooner, J.S., et al. “Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides.” Nat Genet, 2008, 40: 149–151.